The correlation between acoustic cavitation and sonoporation involved in ultrasound-mediated DNA transfection with polyethylenimine (PEI) in vitro
Previous studies have demonstrated that the efficiency of gene/drug delivery can be enhanced under ultrasound (US) exposure with the presence of US contrast agent microbubbles, due to the acoustic cavitation-induced sonoporation. However, obstacles still remain to achieve controllable sonoporation o...
Saved in:
Published in | Journal of controlled release Vol. 145; no. 1; pp. 40 - 48 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Kidlington
Elsevier B.V
01.07.2010
Elsevier |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Previous studies have demonstrated that the efficiency of gene/drug delivery can be enhanced under ultrasound (US) exposure with the presence of US contrast agent microbubbles, due to the acoustic cavitation-induced sonoporation. However, obstacles still remain to achieve controllable sonoporation outcome. The general hypotheses guiding present studies were that inertial cavitation (IC) activities accumulated during US exposure could be quantified as IC dose (ICD) based on passive cavitation detection (PCD), and the assessment of sonoporation outcome should be correlated with ICD measurements. In current work, MCF-7 cells mixed with PEI:DNA complex and UCD microbubbles were exposed to 1-MHz US pulses with 20-cycle pulse and varied acoustic peak negative pressure (
P
−; 0 (sham), 0.3, 0.75, 1.4, 2.2 or 3.0
MPa), total treatment time (0, 5, 10, 20, 40 or 60
s), and pulse-repetition-frequency (PRF; 0, 20, 100, 250, 500, or 1000
Hz). Then, four series experiments were conducted: (1) the IC activities were detected using a PCD system and quantified as ICD; (2) the DNA transfection efficiency was evaluated with flow cytometry; (3) the cell viability was examined by PI dying then measured using flow cytometry; and (4) scan electron microscopy was used to investigate the sonoporation effects on the cell membrane. The results showed that: (1) the ICD generated during US exposure could be affected by US parameters (
e.g.,
P
−, total treatment time, and PRF); (2) the pooled data analyses demonstrated that DNA transfection efficiency initially increased linearly with the increasing ICD, then it tended to saturate instead of trying to achieve a maximum value while the ICD kept going up; and (3) the measured ICD, sonoporation pore size, and cell viability exhibited high correlation among each other. All the results indicated that IC activity should play an important role in the US-mediated DNA transfection through sonoporation, and ICD could be used as an effective tool to monitor and control the US-mediated gene/drug delivery effect.
The elevated inertial cavitation dose (ICD; quantifying cumulative IC energy during sonication) exhibits high correlation with enlarged sonopration pore size, decreased cell viability, and enhanced PEI:DNA transfection efficiency until it reaches a saturation level.
▪ |
---|---|
AbstractList | Previous studies have demonstrated that the efficiency of gene/drug delivery can be enhanced under ultrasound (US) exposure with the presence of US contrast agent microbubbles, due to the acoustic cavitation-induced sonoporation. However, obstacles still remain to achieve controllable sonoporation outcome. The general hypotheses guiding present studies were that inertial cavitation (IC) activities accumulated during US exposure could be quantified as IC dose (ICD) based on passive cavitation detection (PCD), and the assessment of sonoporation outcome should be correlated with ICD measurements. In current work, MCF-7 cells mixed with PEI:DNA complex and UCD microbubbles were exposed to 1-MHz US pulses with 20-cycle pulse and varied acoustic peak negative pressure (P super(-); 0 (sham), 0.3, 0.75, 1.4, 2.2 or 3.0 MPa), total treatment time (0, 5, 10, 20, 40 or 60 s), and pulse-repetition-frequency (PRF; 0, 20, 100, 250, 500, or 1000 Hz). Then, four series experiments were conducted: (1) the IC activities were detected using a PCD system and quantified as ICD; (2) the DNA transfection efficiency was evaluated with flow cytometry; (3) the cell viability was examined by PI dying then measured using flow cytometry; and (4) scan electron microscopy was used to investigate the sonoporation effects on the cell membrane. The results showed that: (1) the ICD generated during US exposure could be affected by US parameters (e.g., P super(-), total treatment time, and PRF); (2) the pooled data analyses demonstrated that DNA transfection efficiency initially increased linearly with the increasing ICD, then it tended to saturate instead of trying to achieve a maximum value while the ICD kept going up; and (3) the measured ICD, sonoporation pore size, and cell viability exhibited high correlation among each other. All the results indicated that IC activity should play an important role in the US-mediated DNA transfection through sonoporation, and ICD could be used as an effective tool to monitor and control the US-mediated gene/drug delivery effect. Previous studies have demonstrated that the efficiency of gene/drug delivery can be enhanced under ultrasound (US) exposure with the presence of US contrast agent microbubbles, due to the acoustic cavitation-induced sonoporation. However, obstacles still remain to achieve controllable sonoporation outcome. The general hypotheses guiding present studies were that inertial cavitation (IC) activities accumulated during US exposure could be quantified as IC dose (ICD) based on passive cavitation detection (PCD), and the assessment of sonoporation outcome should be correlated with ICD measurements. In current work, MCF-7 cells mixed with PEI:DNA complex and UCD microbubbles were exposed to 1-MHz US pulses with 20-cycle pulse and varied acoustic peak negative pressure ( P −; 0 (sham), 0.3, 0.75, 1.4, 2.2 or 3.0 MPa), total treatment time (0, 5, 10, 20, 40 or 60 s), and pulse-repetition-frequency (PRF; 0, 20, 100, 250, 500, or 1000 Hz). Then, four series experiments were conducted: (1) the IC activities were detected using a PCD system and quantified as ICD; (2) the DNA transfection efficiency was evaluated with flow cytometry; (3) the cell viability was examined by PI dying then measured using flow cytometry; and (4) scan electron microscopy was used to investigate the sonoporation effects on the cell membrane. The results showed that: (1) the ICD generated during US exposure could be affected by US parameters ( e.g., P −, total treatment time, and PRF); (2) the pooled data analyses demonstrated that DNA transfection efficiency initially increased linearly with the increasing ICD, then it tended to saturate instead of trying to achieve a maximum value while the ICD kept going up; and (3) the measured ICD, sonoporation pore size, and cell viability exhibited high correlation among each other. All the results indicated that IC activity should play an important role in the US-mediated DNA transfection through sonoporation, and ICD could be used as an effective tool to monitor and control the US-mediated gene/drug delivery effect. The elevated inertial cavitation dose (ICD; quantifying cumulative IC energy during sonication) exhibits high correlation with enlarged sonopration pore size, decreased cell viability, and enhanced PEI:DNA transfection efficiency until it reaches a saturation level. ▪ Previous studies have demonstrated that the efficiency of gene/drug delivery can be enhanced under ultrasound (US) exposure with the presence of US contrast agent microbubbles, due to the acoustic cavitation-induced sonoporation. However, obstacles still remain to achieve controllable sonoporation outcome. The general hypotheses guiding present studies were that inertial cavitation (IC) activities accumulated during US exposure could be quantified as IC dose (ICD) based on passive cavitation detection (PCD), and the assessment of sonoporation outcome should be correlated with ICD measurements. In current work, MCF-7 cells mixed with PEI:DNA complex and UCD microbubbles were exposed to 1-MHz US pulses with 20-cycle pulse and varied acoustic peak negative pressure (P(-); 0 (sham), 0.3, 0.75, 1.4, 2.2 or 3.0MPa), total treatment time (0, 5, 10, 20, 40 or 60s), and pulse-repetition-frequency (PRF; 0, 20, 100, 250, 500, or 1000Hz). Then, four series experiments were conducted: (1) the IC activities were detected using a PCD system and quantified as ICD; (2) the DNA transfection efficiency was evaluated with flow cytometry; (3) the cell viability was examined by PI dying then measured using flow cytometry; and (4) scan electron microscopy was used to investigate the sonoporation effects on the cell membrane. The results showed that: (1) the ICD generated during US exposure could be affected by US parameters (e.g., P(-), total treatment time, and PRF); (2) the pooled data analyses demonstrated that DNA transfection efficiency initially increased linearly with the increasing ICD, then it tended to saturate instead of trying to achieve a maximum value while the ICD kept going up; and (3) the measured ICD, sonoporation pore size, and cell viability exhibited high correlation among each other. All the results indicated that IC activity should play an important role in the US-mediated DNA transfection through sonoporation, and ICD could be used as an effective tool to monitor and control the US-mediated gene/drug delivery effect.Previous studies have demonstrated that the efficiency of gene/drug delivery can be enhanced under ultrasound (US) exposure with the presence of US contrast agent microbubbles, due to the acoustic cavitation-induced sonoporation. However, obstacles still remain to achieve controllable sonoporation outcome. The general hypotheses guiding present studies were that inertial cavitation (IC) activities accumulated during US exposure could be quantified as IC dose (ICD) based on passive cavitation detection (PCD), and the assessment of sonoporation outcome should be correlated with ICD measurements. In current work, MCF-7 cells mixed with PEI:DNA complex and UCD microbubbles were exposed to 1-MHz US pulses with 20-cycle pulse and varied acoustic peak negative pressure (P(-); 0 (sham), 0.3, 0.75, 1.4, 2.2 or 3.0MPa), total treatment time (0, 5, 10, 20, 40 or 60s), and pulse-repetition-frequency (PRF; 0, 20, 100, 250, 500, or 1000Hz). Then, four series experiments were conducted: (1) the IC activities were detected using a PCD system and quantified as ICD; (2) the DNA transfection efficiency was evaluated with flow cytometry; (3) the cell viability was examined by PI dying then measured using flow cytometry; and (4) scan electron microscopy was used to investigate the sonoporation effects on the cell membrane. The results showed that: (1) the ICD generated during US exposure could be affected by US parameters (e.g., P(-), total treatment time, and PRF); (2) the pooled data analyses demonstrated that DNA transfection efficiency initially increased linearly with the increasing ICD, then it tended to saturate instead of trying to achieve a maximum value while the ICD kept going up; and (3) the measured ICD, sonoporation pore size, and cell viability exhibited high correlation among each other. All the results indicated that IC activity should play an important role in the US-mediated DNA transfection through sonoporation, and ICD could be used as an effective tool to monitor and control the US-mediated gene/drug delivery effect. Previous studies have demonstrated that the efficiency of gene/drug delivery can be enhanced under ultrasound (US) exposure with the presence of US contrast agent microbubbles, due to the acoustic cavitation-induced sonoporation. However, obstacles still remain to achieve controllable sonoporation outcome. The general hypotheses guiding present studies were that inertial cavitation (IC) activities accumulated during US exposure could be quantified as IC dose (ICD) based on passive cavitation detection (PCD), and the assessment of sonoporation outcome should be correlated with ICD measurements. In current work, MCF-7 cells mixed with PEI:DNA complex and UCD microbubbles were exposed to 1-MHz US pulses with 20-cycle pulse and varied acoustic peak negative pressure (P(-); 0 (sham), 0.3, 0.75, 1.4, 2.2 or 3.0MPa), total treatment time (0, 5, 10, 20, 40 or 60s), and pulse-repetition-frequency (PRF; 0, 20, 100, 250, 500, or 1000Hz). Then, four series experiments were conducted: (1) the IC activities were detected using a PCD system and quantified as ICD; (2) the DNA transfection efficiency was evaluated with flow cytometry; (3) the cell viability was examined by PI dying then measured using flow cytometry; and (4) scan electron microscopy was used to investigate the sonoporation effects on the cell membrane. The results showed that: (1) the ICD generated during US exposure could be affected by US parameters (e.g., P(-), total treatment time, and PRF); (2) the pooled data analyses demonstrated that DNA transfection efficiency initially increased linearly with the increasing ICD, then it tended to saturate instead of trying to achieve a maximum value while the ICD kept going up; and (3) the measured ICD, sonoporation pore size, and cell viability exhibited high correlation among each other. All the results indicated that IC activity should play an important role in the US-mediated DNA transfection through sonoporation, and ICD could be used as an effective tool to monitor and control the US-mediated gene/drug delivery effect. |
Author | Qiu, Yuanyuan Zhang, Yanli Zhang, Dong Zhang, Junfeng Wu, Junru Tu, Juan Luo, Yi Cui, Weicheng |
Author_xml | – sequence: 1 givenname: Yuanyuan surname: Qiu fullname: Qiu, Yuanyuan organization: Key Laboratory of Modern Acoustics (Nanjing University), Ministry of Education, Nanjing, Jiangsu, 210093, PR China – sequence: 2 givenname: Yi surname: Luo fullname: Luo, Yi organization: State Key Lab of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing 210093, PR China – sequence: 3 givenname: Yanli surname: Zhang fullname: Zhang, Yanli organization: Key Laboratory of Modern Acoustics (Nanjing University), Ministry of Education, Nanjing, Jiangsu, 210093, PR China – sequence: 4 givenname: Weicheng surname: Cui fullname: Cui, Weicheng organization: Key Laboratory of Modern Acoustics (Nanjing University), Ministry of Education, Nanjing, Jiangsu, 210093, PR China – sequence: 5 givenname: Dong surname: Zhang fullname: Zhang, Dong organization: Key Laboratory of Modern Acoustics (Nanjing University), Ministry of Education, Nanjing, Jiangsu, 210093, PR China – sequence: 6 givenname: Junru surname: Wu fullname: Wu, Junru organization: Department of Physics, University of Vermont, Burlington, VT 05405, USA – sequence: 7 givenname: Junfeng surname: Zhang fullname: Zhang, Junfeng organization: State Key Lab of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing 210093, PR China – sequence: 8 givenname: Juan surname: Tu fullname: Tu, Juan email: juantutu@gmail.com organization: Key Laboratory of Modern Acoustics (Nanjing University), Ministry of Education, Nanjing, Jiangsu, 210093, PR China |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=22908456$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/20398711$$D View this record in MEDLINE/PubMed |
BookMark | eNqFks1u1DAUhS1URKeFRwBlg4BFBjuOY0csUFUKVKqARVlbjnOt8ShjD3ZmqnkNnpg7JIDEZlbXuv7O8c-5F-QsxACEPGd0yShr3q6XaxtDgmFZUezReonlEVkwJXlZt604IwvkVMkb0Z6Ti5zXlFLBa_mEnFeUt0oytiA_71dQ2JjQyIw-hqKD8QEgFMbGXR69LazZ-3HaM6EvcgxxG9PU8GEfhz30uCh2w5hMjrvQlxvovRmx_eHLVYHdkB3Y34IHP66KbRwOMK4OAwS_8QGK199ubt8cPfCkFJ-Sx84MGZ7N9ZJ8_3hzf_25vPv66fb66q60tVBjKSt8AucWuLV933DjGJPCta1qDAjW45I74E521MgGnOuc6oQEYdrWdK7il-TV5LtN8ccO8qg3PlsYBhMA366VbCpe06o5SUpRq6ZV9LQnXphxoYRE8sVM7jr8L71NfmPSQf-JBoGXM2CyNYPDb7Q-_-OqlqpaHC8nJs6mmHMC9xdhVB9HRa_1PCr6OCqa1hoL6t79p7NzzpiYH06q309qwIT2HpLO1kOwmHzCrHUf_QmHX3hb4Ig |
CODEN | JCREEC |
CitedBy_id | crossref_primary_10_1016_j_biomaterials_2011_11_015 crossref_primary_10_3390_biomedicines9010032 crossref_primary_10_34133_2022_9807347 crossref_primary_10_1016_j_ultras_2014_10_015 crossref_primary_10_1016_j_ultrasmedbio_2014_11_001 crossref_primary_10_1016_j_jconrel_2011_09_071 crossref_primary_10_1007_s11307_013_0672_5 crossref_primary_10_35848_1347_4065_acbd5c crossref_primary_10_7567_1347_4065_ab4eb1 crossref_primary_10_1016_j_ultrasmedbio_2011_05_012 crossref_primary_10_1021_acsami_8b18418 crossref_primary_10_1038_s44222_024_00166_5 crossref_primary_10_1007_s12195_013_0279_6 crossref_primary_10_1371_journal_pone_0056423 crossref_primary_10_1186_s11671_015_1193_8 crossref_primary_10_1016_j_ultrasmedbio_2020_11_029 crossref_primary_10_1007_s00232_016_9921_2 crossref_primary_10_1260_2040_2295_4_2_223 crossref_primary_10_1016_j_ultsonch_2013_10_017 crossref_primary_10_1016_j_canlet_2019_06_017 crossref_primary_10_1016_j_ultrasmedbio_2013_01_008 crossref_primary_10_1016_j_addr_2013_11_008 crossref_primary_10_1016_j_ultsonch_2023_106346 crossref_primary_10_1063_1_4865770 crossref_primary_10_7498_aps_64_094306 crossref_primary_10_1038_mtm_2016_12 crossref_primary_10_1016_j_jconrel_2011_02_006 crossref_primary_10_1021_acsptsci_0c00212 crossref_primary_10_1089_jop_2022_0114 crossref_primary_10_1371_journal_pone_0277759 crossref_primary_10_3390_brainsci11111429 crossref_primary_10_1109_TUFFC_2019_2897983 crossref_primary_10_1038_s41598_020_64213_y crossref_primary_10_1016_j_addr_2014_03_003 crossref_primary_10_1016_j_ultrasmedbio_2019_10_026 crossref_primary_10_1088_1478_3975_12_6_066007 crossref_primary_10_3389_fimmu_2022_937344 crossref_primary_10_1021_acs_chemrev_1c00622 crossref_primary_10_1088_1361_6560_ace23e crossref_primary_10_4155_tde_12_100 crossref_primary_10_1016_j_ijpharm_2020_119615 crossref_primary_10_1016_j_ultrasmedbio_2016_08_005 crossref_primary_10_3390_molecules29245997 crossref_primary_10_1016_j_addr_2021_02_015 crossref_primary_10_1021_mp300037t crossref_primary_10_1038_srep37728 crossref_primary_10_1371_journal_pone_0113673 crossref_primary_10_1021_acs_langmuir_8b03288 crossref_primary_10_1016_j_jconrel_2011_12_028 crossref_primary_10_1039_D4NR00277F crossref_primary_10_1088_0031_9155_59_22_6729 crossref_primary_10_1016_j_nantod_2023_101804 crossref_primary_10_1016_j_ultsonch_2015_10_006 crossref_primary_10_1038_mtm_2014_7 crossref_primary_10_1016_j_jbiomech_2012_03_011 crossref_primary_10_1021_acs_jpcc_6b04086 crossref_primary_10_1016_j_jddst_2022_103882 crossref_primary_10_1007_s12195_019_00597_w crossref_primary_10_1016_j_apacoust_2021_108056 crossref_primary_10_1016_j_biomaterials_2013_02_067 crossref_primary_10_1088_1674_1056_26_5_054301 crossref_primary_10_1016_j_actbio_2021_06_015 crossref_primary_10_1016_j_febslet_2012_12_005 crossref_primary_10_1016_j_ultsonch_2016_06_017 crossref_primary_10_1016_j_colsurfb_2017_10_036 crossref_primary_10_1016_j_ultsonch_2012_12_005 crossref_primary_10_1088_0256_307X_31_3_034302 crossref_primary_10_1016_j_ultsonch_2023_106685 crossref_primary_10_1016_j_ultras_2023_107227 crossref_primary_10_1016_j_bspc_2020_102235 crossref_primary_10_1016_j_ultsonch_2023_106723 crossref_primary_10_1016_j_jconrel_2018_01_014 crossref_primary_10_1021_jz502513w crossref_primary_10_1016_j_ultsonch_2023_106563 crossref_primary_10_1109_TUFFC_2013_2534 crossref_primary_10_1016_j_ultsonch_2020_105096 crossref_primary_10_1016_j_ultrasmedbio_2020_03_013 crossref_primary_10_1021_acs_chemrev_5b00346 crossref_primary_10_1371_journal_pone_0076544 crossref_primary_10_7567_JJAP_56_047201 crossref_primary_10_3390_pharmaceutics15051463 crossref_primary_10_1016_j_ultrasmedbio_2012_08_025 crossref_primary_10_1016_j_ultsonch_2013_08_019 crossref_primary_10_3390_pharmaceutics16111383 crossref_primary_10_3390_molecules28237733 crossref_primary_10_1016_j_jconrel_2020_10_068 crossref_primary_10_1016_j_jddst_2022_103386 crossref_primary_10_1007_s11095_014_1332_4 crossref_primary_10_1002_admt_201800081 crossref_primary_10_1016_j_ultrasmedbio_2021_07_004 crossref_primary_10_1021_acs_langmuir_8b03538 crossref_primary_10_1038_s41598_018_22056_8 crossref_primary_10_1121_1_4927413 crossref_primary_10_1016_j_jconrel_2018_01_001 crossref_primary_10_1155_2017_3273816 crossref_primary_10_1016_j_ultsonch_2015_12_001 crossref_primary_10_1016_j_colsurfb_2020_110849 crossref_primary_10_1021_acs_molpharmaceut_5b00347 crossref_primary_10_1016_j_ultrasmedbio_2012_06_008 crossref_primary_10_1088_1674_1056_21_7_074301 crossref_primary_10_1109_TUFFC_2016_2620492 crossref_primary_10_1016_j_ultsonch_2020_105439 crossref_primary_10_1021_acsami_5b02832 crossref_primary_10_1016_j_bioelechem_2022_108153 crossref_primary_10_1016_j_ultsonch_2024_106888 crossref_primary_10_1016_j_ijpharm_2014_12_013 crossref_primary_10_1016_j_jconrel_2012_07_005 crossref_primary_10_1016_j_ultrasmedbio_2018_04_005 crossref_primary_10_1016_j_ultrasmedbio_2016_10_003 crossref_primary_10_1080_10717544_2017_1319433 crossref_primary_10_1158_0008_5472_CAN_15_3231 crossref_primary_10_2139_ssrn_3981539 crossref_primary_10_1016_j_ultsonch_2019_03_031 crossref_primary_10_1016_j_bioelechem_2024_108708 crossref_primary_10_1016_j_ultsonch_2024_107051 crossref_primary_10_3109_1061186X_2014_921922 crossref_primary_10_1016_j_ultrasmedbio_2016_01_021 crossref_primary_10_3390_pharmaceutics13050640 crossref_primary_10_1016_j_ultsonch_2018_07_031 crossref_primary_10_1038_s41598_019_49386_5 crossref_primary_10_1121_10_0010534 crossref_primary_10_1007_s13277_015_4681_7 crossref_primary_10_1021_nn3045243 crossref_primary_10_1088_1674_1056_25_12_124308 crossref_primary_10_1016_j_irbm_2018_11_005 crossref_primary_10_1016_j_ultrasmedbio_2013_08_003 crossref_primary_10_1088_0256_307X_33_8_084302 crossref_primary_10_1016_j_ultsonch_2019_01_005 crossref_primary_10_1021_acs_molpharmaceut_6b00761 crossref_primary_10_1039_C9NR03402A crossref_primary_10_1063_1_3660352 crossref_primary_10_1021_acs_jpcb_5b02218 crossref_primary_10_1016_j_measurement_2024_114372 crossref_primary_10_1016_j_inoche_2024_113765 crossref_primary_10_1117_1_JBO_21_4_045003 crossref_primary_10_3233_THC_199025 crossref_primary_10_1016_j_ultrasmedbio_2014_01_011 crossref_primary_10_1073_pnas_1713328114 crossref_primary_10_1080_10717544_2017_1422300 crossref_primary_10_1016_j_jconrel_2012_08_014 crossref_primary_10_1007_s12013_013_9523_x crossref_primary_10_1016_j_apacoust_2020_107384 crossref_primary_10_1016_j_ijpharm_2013_08_041 crossref_primary_10_1039_D3NR02562D crossref_primary_10_3390_biomedicines9070803 crossref_primary_10_3390_pharmaceutics11050244 crossref_primary_10_1038_s44172_024_00265_6 crossref_primary_10_1016_j_ultrasmedbio_2015_05_003 crossref_primary_10_12659_MSM_898323 crossref_primary_10_1016_j_jconrel_2017_07_004 |
ContentType | Journal Article |
Copyright | 2010 Elsevier B.V. 2015 INIST-CNRS 2010 Elsevier B.V. All rights reserved. |
Copyright_xml | – notice: 2010 Elsevier B.V. – notice: 2015 INIST-CNRS – notice: 2010 Elsevier B.V. All rights reserved. |
DBID | AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 7X8 7QO 7TM 8FD FR3 P64 |
DOI | 10.1016/j.jconrel.2010.04.010 |
DatabaseName | CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic Biotechnology Research Abstracts Nucleic Acids Abstracts Technology Research Database Engineering Research Database Biotechnology and BioEngineering Abstracts |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic Engineering Research Database Biotechnology Research Abstracts Technology Research Database Nucleic Acids Abstracts Biotechnology and BioEngineering Abstracts |
DatabaseTitleList | Engineering Research Database MEDLINE - Academic Engineering Research Database MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Pharmacy, Therapeutics, & Pharmacology |
EISSN | 1873-4995 |
EndPage | 48 |
ExternalDocumentID | 20398711 22908456 10_1016_j_jconrel_2010_04_010 S0168365910002646 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- --K --M .GJ .~1 0R~ 1B1 1RT 1~. 1~5 29K 3O- 4.4 457 4G. 53G 5GY 5VS 7-5 71M 8P~ 9JM AABNK AABXZ AACTN AAEDT AAEDW AAIAV AAIKJ AAKOC AALRI AAOAW AAQFI AAQXK AATCM AAXUO AAYOK ABFNM ABFRF ABJNI ABMAC ABOCM ABXDB ABYKQ ABZDS ACDAQ ACGFO ACGFS ACIUM ACNNM ACRLP ADBBV ADEZE ADMUD AEBSH AEFWE AEKER AENEX AEZYN AFKWA AFRZQ AFTJW AFXIZ AGHFR AGUBO AGYEJ AHHHB AIEXJ AIKHN AITUG AJBFU AJOXV ALCLG ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC C45 CS3 D-I DU5 EBS EFJIC EFLBG EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN G-2 G-Q GBLVA HMT HVGLF HZ~ IHE J1W KOM M34 M41 MO0 N9A O-L O9- OAUVE OGGZJ OVD OZT P-8 P-9 P2P PC. Q38 R2- RIG RNS ROL RPZ SCC SDF SDG SDP SES SEW SPC SPCBC SPT SSM SSP SSZ T5K TEORI WUQ ~G- AAHBH AATTM AAXKI AAYWO AAYXX ABWVN ACRPL ACVFH ADCNI ADNMO AEIPS AEUPX AFPUW AGCQF AGRNS AIIUN AKBMS AKRWK AKYEP ANKPU CITATION SSH AFJKZ AGQPQ AIGII APXCP BNPGV EFKBS IQODW CGR CUY CVF ECM EIF NPM 7X8 7QO 7TM 8FD FR3 P64 |
ID | FETCH-LOGICAL-c458t-7298733ce3ccdd63af1175f9986ae51d5f93fe3f7b0a76effbf8b57e5a99abf23 |
IEDL.DBID | AIKHN |
ISSN | 0168-3659 1873-4995 |
IngestDate | Fri Jul 11 02:17:12 EDT 2025 Thu Jul 10 17:48:20 EDT 2025 Mon Jul 21 10:47:08 EDT 2025 Mon Jul 21 05:57:57 EDT 2025 Mon Jul 21 09:11:10 EDT 2025 Tue Jul 01 04:04:04 EDT 2025 Thu Apr 24 23:03:48 EDT 2025 Fri Feb 23 02:28:54 EST 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | Inertial cavitation dose Ultrasound-mediated gene/drug delivery PEI Sonoporation Ultrasound contrast agents Correlation Pharmaceutical technology Drug carrier In vitro Genetic transfer Polyelectrolyte Transfection DNA Ultrasound contrast agent Olefinimine polymer Gene therapy Ultrasound Nucleic acid Polyethylene imine |
Language | English |
License | https://www.elsevier.com/tdm/userlicense/1.0 CC BY 4.0 2010 Elsevier B.V. All rights reserved. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c458t-7298733ce3ccdd63af1175f9986ae51d5f93fe3f7b0a76effbf8b57e5a99abf23 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 ObjectType-Article-2 ObjectType-Feature-1 |
PMID | 20398711 |
PQID | 733135857 |
PQPubID | 23462 |
PageCount | 9 |
ParticipantIDs | proquest_miscellaneous_876234026 proquest_miscellaneous_754869802 proquest_miscellaneous_733135857 pubmed_primary_20398711 pascalfrancis_primary_22908456 crossref_primary_10_1016_j_jconrel_2010_04_010 crossref_citationtrail_10_1016_j_jconrel_2010_04_010 elsevier_sciencedirect_doi_10_1016_j_jconrel_2010_04_010 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2010-07-01 |
PublicationDateYYYYMMDD | 2010-07-01 |
PublicationDate_xml | – month: 07 year: 2010 text: 2010-07-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | Kidlington |
PublicationPlace_xml | – name: Kidlington – name: Netherlands |
PublicationTitle | Journal of controlled release |
PublicationTitleAlternate | J Control Release |
PublicationYear | 2010 |
Publisher | Elsevier B.V Elsevier |
Publisher_xml | – name: Elsevier B.V – name: Elsevier |
References | Boletta, Benigni, Lutz, Remuzzi, Soria, Monaco (bib8) 1997; 8 Van Wamel, Kooiman, Harteveld, Emmer, ten Cate, Versluis, de Jong (bib16) 2006; 112 Leborgne, Coeytaux, Danos (bib24) 2001; 3 Miller, Pislaru, Greenleaf (bib19) 2002; 27 Ferrara, Pollard, Borden (bib12) 2007; 9 Anderson (bib1) 1992; 256 Prasad, Wang, Hill, Zhang (bib2) 2004; 4 Mitragotri (bib11) 2005; 4 Kudo, Okada, Yamamoto (bib27) 2009; 96 Lemkine, Goula, Becher, Paleari, Levi, Demeneix (bib29) 1999; 7 Yang, Gu, Chen, Xi, Zhang, Li, Wu (bib32) 2008; 131 Newman, Bettinger (bib18) 2007; 14 Guzman, Nguyen, Khan, Prausnitz (bib30) 2001; 110 Wilson (bib4) 2002; 3 Apfel, Holland (bib20) 1991; 17 Tu, Matula, Brayman, Crum (bib23) 2006; 32 Everbach, Makin, Azadniv, Meltzer (bib26) 1997; 23 Han, Ikegami, Chung, Zhang, Deng (bib34) 2007; 73 Neu, Fischer, Kissel (bib7) 2005; 7 Sophie, Thierry, Feng, Guy (bib15) 2005; 104 Kicheler, Leborgne, Coeytaux, Danos (bib9) 2001; 3 Lungwitz, Breuning, Blunk (bib6) 2005; 60 Deng, Xu, Apfel, Holland (bib21) 1996; 22 Mehier-Humbert, Guy (bib3) 2005; 57 Deshpande, Prausnitz (bib10) 2007; 118 Schelicher, Radhakrishna, Tolentino, Apkarian, Zamitsyn, Prausnitz (bib31) 2006; 32 Cramer, Lauterborn (bib25) 1982; 38 Erbacher, Bettinger, Belguise-Valladier, Zou, Coll, Behr, Remy (bib33) 1999; 1 Tsivgoulis, Alexandrov (bib13) 2007; 4 Chang, Chen, Mourad, Poliachik, Crum (bib22) 2001; 48 Wu, Jason, Mercedes (bib17) 2006; 44 Niidome, Huang (bib5) 2002; 9 Rosenthal, Sostaric, Riesz (bib14) 2004; 11 Zamitsyn, Rostad, Prausnitz (bib28) 2008; 95 |
References_xml | – volume: 73 start-page: 3677 year: 2007 end-page: 3683 ident: bib34 article-title: Sonoporation is an efficient tool for intracellular fluorescent dextran delivery and one-step double-crossover mutant construction in publication-title: Appl. Environ. Microbiol. – volume: 3 start-page: 135 year: 2001 end-page: 144 ident: bib9 article-title: Polyethyleneimine-mediated gene delivery: a mechanistic study publication-title: J. Gene Med. – volume: 1 start-page: 210 year: 1999 end-page: 222 ident: bib33 article-title: Transfection and physical properties of various saccharide, poly (ethylene glycol), and antibody-derivatized polyethylenimines (PEI) publication-title: J. Gene Med. – volume: 96 start-page: 4866 year: 2009 end-page: 4876 ident: bib27 article-title: Sonoporation by single-shot pulsed ultrasound with microbubbles adjacent to cells publication-title: Biophys. J. – volume: 44 start-page: e21 year: 2006 end-page: e25 ident: bib17 article-title: Sonoporation, anti-cancer drug and antibody delivery using ultrasound publication-title: Ultrasonics – volume: 48 start-page: 161 year: 2001 end-page: 170 ident: bib22 article-title: Thresholds for inertial cavitation in Albunex suspesions under pulsed ultrasound conditions publication-title: IEEE Trans. Ultra. Ferro. Freq. control – volume: 3 start-page: 135 year: 2001 end-page: 144 ident: bib24 article-title: Polyethyleneimine-mediated gene delivery: a mechanistic study publication-title: J. Gene Med. – volume: 112 start-page: 149 year: 2006 end-page: 155 ident: bib16 article-title: vibrating microbubbles poling individual cells: drug transfer into cells via sonoporation publication-title: J. Control. Release – volume: 9 start-page: 1647 year: 2002 end-page: 1652 ident: bib5 article-title: Gene therapy progress and prospects: nonviral vectors publication-title: Gene Ther. – volume: 57 start-page: 733 year: 2005 end-page: 753 ident: bib3 article-title: Physical methods for gene transfer: improving the kinetics of gene delivery into cells publication-title: Adv. Drug. Deliv. Rev. – volume: 9 start-page: 415 year: 2007 end-page: 447 ident: bib12 article-title: Ultrasound microbubble contrast agents: fundermental and application to gene and drug delivery publication-title: Annu. Rev. Biomed. Eng. – volume: 32 start-page: 281 year: 2006 end-page: 288 ident: bib23 article-title: Inertial cavitation dose produced in ex vivo rabbit ear arteries by 1-MHz insonation treatment during infusion with optison publication-title: Ultra. Med. Biol. – volume: 110 start-page: 588 year: 2001 end-page: 596 ident: bib30 article-title: Ultrasound-mediated distruption of cell membranes. I. Quantification of molecular uptake and cell viability publication-title: J. Acoust. Soc. Am. – volume: 17 start-page: 179 year: 1991 end-page: 185 ident: bib20 article-title: Gauging the likelihood of cavitation from short-pulse, low-duty cycle diagnostic ultrasound publication-title: Ultra. Med. Biol – volume: 60 start-page: 247 year: 2005 end-page: 266 ident: bib6 article-title: Polyethylenimine-based non-viral gene delivery systems publication-title: Eur. J. Pharm. Biopharm. – volume: 32 start-page: 915 year: 2006 end-page: 924 ident: bib31 article-title: Mechanism of intracellular delivery by acoustic cavitation publication-title: Ultra. Med. Biol. – volume: 7 start-page: 305 year: 1999 end-page: 312 ident: bib29 article-title: Optimisation of oplyethylenimine based gene delivery to mouse braine publication-title: J. Drug Target – volume: 3 start-page: 151 year: 2002 end-page: 164 ident: bib4 article-title: Viral-mediated gene transfer for cancer treatment publication-title: Curr. Pharm. Biotechnol. – volume: 4 start-page: 420 year: 2007 end-page: 427 ident: bib13 article-title: Ultrasound-enhanced thrombolysis in acute ischemic stroke: potential, failures, and safety publication-title: Neurotherapeutics – volume: 4 start-page: 347 year: 2004 end-page: 361 ident: bib2 article-title: Recent advances in experimental molecular therapeutics for malignant gliomas publication-title: Curr. Med. Chem. Anti-cancer Agents – volume: 7 start-page: 992 year: 2005 end-page: 1009 ident: bib7 article-title: Recent advances in rational gene transfer vector design based on poly(ethylene imine) and its derivatives publication-title: J. Gene Med. – volume: 11 start-page: 349 year: 2004 end-page: 363 ident: bib14 article-title: Sonodynamic therapy—a review of the synergistic effects of drugs and ultrasound publication-title: Ultra. Sonochem. – volume: 27 start-page: 115 year: 2002 end-page: 134 ident: bib19 article-title: Sonoporation: mechanical DNA delivery by ultrasonic cavitation publication-title: Cell Mol. Genet. – volume: 4 start-page: 255 year: 2005 end-page: 260 ident: bib11 article-title: Healing sound: the use of ultrasound in drug delivery and other therapeutic applications publication-title: Nat. Rev. Drug Discov. – volume: 38 start-page: 209 year: 1982 end-page: 214 ident: bib25 article-title: Acoustic cavitation noise spectra publication-title: Appl. Sci. Res. – volume: 256 start-page: 808 year: 1992 end-page: 813 ident: bib1 article-title: Human gene therapy publication-title: Science – volume: 14 start-page: 465 year: 2007 end-page: 475 ident: bib18 article-title: Gene therapy progress and prospects: ultrasound for gene transfer publication-title: Gene Ther. – volume: 118 start-page: 126 year: 2007 end-page: 135 ident: bib10 article-title: Synergistic effects of ultrasound and PEI on DNA transfection publication-title: J. Control. Release – volume: 22 start-page: 939 year: 1996 end-page: 948 ident: bib21 publication-title: Ultra. Med. Biol. – volume: 8 start-page: 1243 year: 1997 end-page: 1251 ident: bib8 article-title: Non-viral gene delivery to the rat kidney with poly(ethylenimine) publication-title: Hum. Gene Ther. – volume: 23 start-page: 619 year: 1997 end-page: 624 ident: bib26 article-title: Correlation of ultrasound-induced hemolysis with cavitation detector output publication-title: Ultra. Med. Biol. – volume: 95 start-page: 4124 year: 2008 end-page: 4138 ident: bib28 article-title: Modeling transmembrane transport through cell membrane wounds created by acoustic cavitation publication-title: Biophys. J. – volume: 131 start-page: 205 year: 2008 end-page: 210 ident: bib32 article-title: Experimental study on cell self-sealing during sonoporation publication-title: J. Control. Release – volume: 104 start-page: 213 year: 2005 end-page: 222 ident: bib15 article-title: Plasma membrane poration induced by ultrasound exposure implication for drug delivery publication-title: J. Control. Release |
SSID | ssj0005347 |
Score | 2.4135487 |
Snippet | Previous studies have demonstrated that the efficiency of gene/drug delivery can be enhanced under ultrasound (US) exposure with the presence of US contrast... |
SourceID | proquest pubmed pascalfrancis crossref elsevier |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 40 |
SubjectTerms | Biological and medical sciences Cell Line, Tumor Cell Survival - physiology DNA - administration & dosage DNA - genetics Drug Carriers - chemistry Gene Transfer Techniques General pharmacology Green Fluorescent Proteins - genetics Humans Inertial cavitation dose Medical sciences Microscopy, Electron, Scanning PEI Pharmaceutical technology. Pharmaceutical industry Pharmacology. Drug treatments Phonophoresis Plasmids Polyethyleneimine - chemistry Sonication Sonoporation Transfection Ultrasound contrast agents Ultrasound-mediated gene/drug delivery |
Title | The correlation between acoustic cavitation and sonoporation involved in ultrasound-mediated DNA transfection with polyethylenimine (PEI) in vitro |
URI | https://dx.doi.org/10.1016/j.jconrel.2010.04.010 https://www.ncbi.nlm.nih.gov/pubmed/20398711 https://www.proquest.com/docview/733135857 https://www.proquest.com/docview/754869802 https://www.proquest.com/docview/876234026 |
Volume | 145 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1ba9swFBa9vAzG2L1Zt6CHUTaoEzuyZfkxdC3pxkJgLfRNSLIECcExiVvIy37EfnHPseWawtpCnyISKb6co3Oxv3M-Qr5mynFhUx3A1skCsH5poLSAEWda5QLylhiLk39P-eQy_nmVXO2Qk7YWBmGV3vY3Nr221v6bob-bw3I-H_6BYEUwnmT4hBrcOt8l-yOWcVDt_fH5r8m0Q3qwuKma5iLABV0hz3AxWEDaubZLD_KKByHW0v7fRb0s1QZunGsYLx4OSWvXdPaavPIxJR03p_2G7NjiLTmaNU2pt8f0oqux2hzTIzrr2lVv35F_8DM1SNLRwOKoh25RmFFTfVGjbnwnb6qKnEKEviq95tB5AfbtxuYwoNfLaq02yNMU1AUpEMzSH9MxrerguMZ8FRQf_NJytdxaUBFwecgqZum32en5d_wPONJ69Z5cnp1enEwCz9QQmDgRFfLhipQxY5kxec6ZctgB1EEqx5VNohyGzFnmUh2qlFvntBM6SW2iskxpN2IfyF6xKuwBodykBl82KsdcPNKptomxECRFmptMR6xH4lY40viLRzaNpWzxagvpZSpRpjKMJXz0yOBuWdn08XhqgWglL-8ppARf89TS_j1NuTsg9tYXELH2CG1VR8Juxlc0qrAgU4kMmgwyuPSRKZBj8kyEo4enoIdjMWyKHvnYKGZ3CiEDUUXRp-df3iF50UAoELP8mexV62v7BSKzSvfJ7uBv1Pf77xakJD38 |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1ba9swFBZd97DBGLt22aXTwygb1IkTybL8WLqWdGtDYCn0TUiyBAnBMYlbyEt_RH_xzrHlZoV1hT1Z2JJv526fcz5CvmTaC-lSE4HoZBFovzTSRsJIMKNzCXELx-Lks5EYnvMfF8nFFjlsa2EwrTLo_kan19o67OmFt9krp9PeL3BWJBNJhl-owayLR-QxB_FF6exe_5HnwXhTMy1khNM3ZTy9WXcGQefSzUOKF-_GWEn7dwP1rNQreG2-wbu43yGtDdPxC_I8eJT0oLnpl2TLFa_I3rhpSb3ep5NNhdVqn-7R8aZZ9fo1uYHD1CJER5MUR0PiFoUZNdAXtfoq9PGmusgp-OeLMvANnRag3a5cDgN6Oa-WeoUoTVFdjgKuLP0-OqBV7RrXGV8Fxc--tFzM1w4YBAweYoo5-nV8dPINzwFXWi7ekPPjo8nhMAo4DZHliawQDVemjFnHrM1zwbTH_p8eAjmhXdLPYci8Yz41sU6F8954aZLUJTrLtPED9pZsF4vCvSNU2NTir0btmecDkxqXWAcuUt8Im5k-6xDeEkfZ8PCIpTFXbbbaTAWaKqSpirmCTYd0b5eVTRePhxbIlvLqDjsqsDQPLd29wym3F8TO-hL81Q6hLesokGX8QaMLBzRViJ_JIH5L_zEFIkyRyXhw_xS0b4yDSHTITsOYm1uIGZCq33___4_3mTwZTs5O1enJ6OcH8rRJpsDs5Y9ku1peuk_go1Vmt5bB309kPsA |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+correlation+between+acoustic+cavitation+and+sonoporation+involved+in+ultrasound-mediated+DNA+transfection+with+polyethylenimine+%28PEI%29+in+vitro&rft.jtitle=Journal+of+controlled+release&rft.au=Qiu%2C+Yuanyuan&rft.au=Luo%2C+Yi&rft.au=Zhang%2C+Yanli&rft.au=Cui%2C+Weicheng&rft.date=2010-07-01&rft.issn=1873-4995&rft.eissn=1873-4995&rft.volume=145&rft.issue=1&rft.spage=40&rft_id=info:doi/10.1016%2Fj.jconrel.2010.04.010&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0168-3659&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0168-3659&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0168-3659&client=summon |